Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous bone marrow-derived mesenchymal stem cells + biphasic calcium phosphate (University of Bergen)
- Development stage
- Unknown
- Lead developer
- University of Bergen
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Subperiosteal
01
Overview
This investigational cell therapy, developed by the University of Bergen, consists of autologous bone marrow-derived mesenchymal stem cells (MSCs) combined with biphasic calcium phosphate (BCP) granules. The MSCs are harvested from the patient's posterior iliac crest, expanded ex vivo in a culture medium supplemented with human platelet lysate, and then seeded onto the BCP scaffold. The resulting graft is implanted subperiosteally to treat severe mandibular alveolar ridge atrophy (bone resorption), providing a regenerative alternative to traditional autologous bone grafting. The therapy aims to restore sufficient bone volume and quality to allow for the successful placement of dental implants in patients with significant bone loss.
- Other names
- MSC and BCP for Mandibular Alveolar Ridge Reconstructionautologous BMMSCs + BCPBCP with autologous mesenchymal stem cells (MSC)
Beyond the preview
Go deeper on autologous bone marrow-derived mesenchymal stem cells + biphasic calcium phosphate (University of Bergen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous bone marrow-derived mesenchymal stem cells + biphasic calcium phosphate (University of Bergen).